ERBB2 and endometrioid adenocarcinoma: Indeed, endometrial serous carcinoma has been found as the histology showing the highest frequency of ERBB2 amplification, up to 38%, followed by other subtypes likewise clear cell or endometrioid carcinoma as pointed out by a study evaluating 2042 endometrial carcinomas [43].